The database does not contain information on compounds that have DTP confidentiality agreements. Access to the database is provided through two avenues: a typical physical constants template, or through a detailed (users need to know their chemistry) structure-searching plug-in supplied by ...
Screening of NCI-DTP library for Lyme disease VR Pothineni et al luminescence was measured in relative luminescence units on a Flex Station 3 Microplate Reader (Molecular Devices LLC, Sunnyvale, CA, USA). The data was analyzed and interpreted by MDL Assay Explorer (Elsevier MDL, San Ramon, ...
温度:37摄氏度,培养箱湿度为70%-80%。 冻存条件 冻存液:90%FBS,DMSO 10%, 或使用非程序冻存液:官网货号SHC703 保藏机构 NCI-DTP:NCI-H3255 产品使用 仅限于科学研究,不可作为动物或人类疾病的治疗产品使用。上一个: 人胃癌细胞OCUM-... 下一个: 人小细胞肺癌细胞NC... 关注我们 ...
In 1995, a formal programme for of the late Kenneth Paull for use by NCI staff, the molecular characterization of the NCI60 were later incorporated into the DTP public was established, together with the centralized website for use by the wider cancer research DTP public web site for the ...
As the drug discovery and developmental arm of the National Cancer Institute (NCI), the Developmental Therapeutics Program (DTP) plans, conducts and facilitates development of therapeutic agents for cancer and AIDS. DTP's goal is to turn,molecules into medicine for the public health'. Areas of ...
保藏机构 ATCC; CRL-5876 CLS; 305137 NCI-DTP; NCI-H1568 供应限制 仅供科研使用 公司简介 售后服务 相关视频 暂无 资料下载 暂无 联系方式 在线询价 *姓名: *单位: 职位: *手机: *邮箱: 地址: *地区: 资料: 需要 不需要 报价: 需要 不需要 留言: 我对您的“NCI-H1568 [H15...
NCI的DTP艾滋病数据的分析[9]或基因调控的预测[4]。 翻译结果2复制译文编辑译文朗读译文返回顶部 NCI DTP HIV 数据的分析 (9) 或基因规则预言 (4)。 翻译结果3复制译文编辑译文朗读译文返回顶部 NCI DTP 艾滋病毒数据 [9] 或 [4] 基因调控预测的分析。 翻译结果4复制译文编辑译文朗读译文返回顶部 对NCI DTP...
保藏机构:ATCC; HTB-175 CLS; 300442 DSMZ; ACC-556 KCLB; 30175 NCI-DTP; NCI-H82 细胞收到后处理: 细胞在培养瓶中培养至良好状态后灌满完全培养液并封好瓶口是细胞运输的最好办法。收到细胞回到自己的实验室后,先打开外包装,用75%酒精喷洒整个瓶消毒后放到超净台内,严格无菌操作,培养箱静置2-4小时。
Diversity Set II Information 见下：http://dtp.nci.nih.gov/branches/dscb/div2_explanation.html 谢...
programme initiated DTP programme review Salicylihalamide ident ied as vATPase inhibitor Demonstration o MEK dependence in melanomas with µBRAF Halichondrin B decision network presentation PS-341 submitted or screening PS-341 INDA iled Bortezomib NDA ...